Nutritional injection for mammals and preparation method thereof
By preparing injections containing nutrients such as calcium, potassium, phosphorus, and magnesium, the problem of postpartum nutritional deficiency in mammals is solved, and rapid and effective nutritional supplementation is achieved, avoiding the deficiency of relying on one's own digestive and absorption capacity.
Patent Information
- Application Number
- CN202411120972.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-15
- Publication Date
- 2024-11-22
AI Technical Summary
Mammals are prone to lack of nutrients and energy after delivery, which leads to diseases such as postpartum paralysis caused by calcium deficiency. Existing supplementary products rely on their insufficient absorption capacity and cannot effectively supplement nutrition.
Provide a nutritional injection solution for mammals, containing calcium, potassium, phosphorus, magnesium, glucose, metal ion complexing agent and activated carbon. Through specific formulas and preparation methods, a suitable pH range is formed to improve glucose stability. , form an injection form for nutritional supplements.
This nutritional injection can effectively supplement a variety of nutrient elements and energy, avoid diseases caused by postpartum nutritional deficiency, take effect quickly, does not rely on the mammal's own digestive and absorption capacity, and provides good nutritional supplement effects.
Smart Images

Figure CN118987028A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of veterinary medicines, and in particular to a nutrient injection solution for mammals and a preparation method thereof. Background Art
[0002] Mammals are prone to nutrient and energy deficiencies after childbirth, which can easily lead to diseases, such as postpartum paralysis caused by calcium deficiency. Currently, common products for supplementing nutrients and energy are usually in the form of food, such as pills, nutritional creams, and food. These products rely on the mammals' own absorption capacity, resulting in some mammals not being able to get good nutritional supplements, which can lead to diseases. Summary of the invention
[0003] The present application provides a nutrient injection solution for mammals and a preparation method thereof, so as to improve the problem that mammals cannot obtain good nutritional supplements at present.
[0004] In the first aspect, the present application provides a nutritional injection solution for mammals, wherein the ingredients of the nutritional injection solution include, by mass fraction: 0.6% to 5% calcium, 0.5% to 3.8% potassium, 0.05% to 2.0% phosphorus, 0.02% to 1.5% magnesium, 5% to 30% glucose, 0.05% to 1.0% metal ion chelating agent, and 0.02% to 1.5% activated carbon, with the remainder being injection solution solvent.
[0005] As an optional embodiment, the ingredients of the nutrient injection solution include, by mass fraction: 0.8% to 3.5% calcium, 0.6% to 3.4% potassium, 0.1% to 1.5% phosphorus, 0.05% to 1.0% magnesium, 5% to 30% glucose, 0.05% to 1.0% metal ion complexing agent, and 0.02% to 1.5% activated carbon, with the rest being injection solution solvent.
[0006] As an optional embodiment, the ingredients of the nutrient injection solution include, by mass fraction: 1% to 3% calcium, 0.8% to 2.4% potassium, 0.25% to 1.0% phosphorus, 0.1% to 0.8% magnesium, 5% to 30% glucose, 0.05% to 1.0% metal ion complexing agent, and 0.02% to 1.5% activated carbon, with the rest being injection solution solvent.
[0007] As an optional embodiment, the calcium supply material includes at least one of calcium chloride, calcium gluconate and calcium lactate.
[0008] As an optional embodiment, the potassium supply material includes at least one of potassium chloride and dipotassium hydrogen phosphate.
[0009] As an optional embodiment, the phosphorus supply material includes at least one of dipotassium hydrogen phosphate, potassium dihydrogen phosphate and disodium hydrogen phosphate.
[0010] As an optional embodiment, the magnesium supply material includes at least one of magnesium chloride and magnesium sulfate.
[0011] As an optional embodiment, the metal ion complexing agent includes at least one of EDTA disodium salt (EDTA-2Na), citric acid and tartaric acid.
[0012] As an optional implementation, the ingredients of the nutrient injection solution further include: 0.5% to 5.0% vitamins by mass.
[0013] As an optional embodiment, the vitamins include at least one of B vitamins and vitamin C.
[0014] As an optional embodiment, the ingredients of the nutrient injection solution further include: 2.0% to 5.0% amino acids by mass fraction.
[0015] As an optional embodiment, the amino acid includes at least one of glutamic acid, lysine and arginine.
[0016] As an optional embodiment, the pH value of the nutrient injection solution is 3.0-6.5.
[0017] In a second aspect, the present application provides a method for preparing a nutrient injection solution for mammals, wherein the nutrient injection solution is the nutrient injection solution described in the first aspect; the preparation method comprises the following steps:
[0018] 1) obtaining an injection solvent;
[0019] 2) mixing the supply materials of calcium, potassium, phosphorus and magnesium with part of the injection solvent, then adding glucose and a metal ion complexing agent, and adjusting the pH value to acidic to obtain a mixed solution;
[0020] 3) mixing the remaining injection solvent with the mixed solution to obtain a semi-finished product;
[0021] 4) Mixing the semi-finished product with activated carbon, and then filtering to obtain an injection solution.
[0022] As an optional embodiment, the step 2) further comprises: mixing the supply materials of calcium, potassium, phosphorus and magnesium with part of the injection solvent, and then adding at least one of vitamins and amino acids.
[0023] As an optional implementation, in the step 2), the pH value of the mixed solution is 3.0 to 6.5.
[0024] In the present invention, by controlling the pH value range of the mixed solution, the stability of glucose in the nutrient injection solution is improved, thereby facilitating the provision of energy for postpartum mammalian mothers.
[0025] As an optional implementation, an inorganic acid or an organic acid is used to adjust the pH value to acidic.
[0026] As an optional embodiment, the inorganic acid includes at least one of hydrochloric acid and boric acid.
[0027] As an optional embodiment, the organic acid includes lactic acid.
[0028] As an optional embodiment, the filtration includes primary filtration and secondary filtration, the diameter of the filter pores of the filter element of the primary filtration is 0.4-0.5 microns, and the diameter of the filter pores of the filter element of the secondary filtration is 0.2-0.3 microns.
[0029] The above technical solution provided by this application has the following advantages compared with the prior art:
[0030] The nutrient injection provided in the embodiment of the present application can simultaneously supplement multiple elements such as calcium, phosphorus, magnesium, potassium, etc., and can effectively supplement the nutrient elements and energy of mammals after childbirth, and avoid diseases caused by the lack of nutrient elements and energy in mammals after childbirth. At the same time, the injection is in the form of an injection, which does not rely on the digestion and absorption capacity of the mammal itself, can achieve a good nutritional supplement effect, and the administration takes effect quickly. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments consistent with the present application and, together with the description, serve to explain the principles of the present application.
[0032] In order to more clearly illustrate the embodiments of the present application or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, for ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative work.
[0033] Figure 1 The figure is a schematic flow chart of a method for preparing a nutrient injection solution for mammals according to the present application. DETAILED DESCRIPTION
[0034] In order to make the purpose, technical solution and advantages of the embodiments of the present application clearer, the technical solution in the embodiments of the present application will be clearly and completely described below in conjunction with the drawings in the embodiments of the present application. Obviously, the described embodiments are part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of this application.
[0035] Unless otherwise specified, various raw materials, reagents, instruments and equipment used in this application can be purchased from the market or prepared by existing methods.
[0036] Some embodiments of the present application provide a nutrient injection for mammals, wherein the ingredients of the nutrient injection include, by mass fraction: 0.6% to 5% (e.g., 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4% or 4.5%) calcium, 0.5% to 3.8% (e.g., 1%, 1.5%, 2%, 2.5%, 3% or 3.5%) potassium, 0.05% to 2.0% (e.g., 0.1%, 0.3%, 0.5%, 0.8%, 1%, 1.2%, 1.5% or 1.8%) phosphorus, 0.02% to 1.5% (e.g., 0. 0.05%, 0.1%, 0.3%, 0.5%, 0.8%, 1%, 1.2% or 1.4%), glucose 5%-30% (for example, 5%, 10%, 15%, 18%, 20%, 22%, 25% or 28%), metal ion complexing agent 0.05%-1.0% (for example, 0.05%, 0.1%, 0.3%, 0.5%, 0.8% or 1%) and activated carbon 0.02%-1.5% (for example, 0.05%, 0.1%, 0.3%, 0.5%, 0.8%, 1%, 1.2% or 1.4%), and the rest is injection solvent.
[0037] In some embodiments, the calcium supply material includes at least one of calcium gluconate and calcium lactate; the potassium supply material includes at least one of potassium chloride and dipotassium hydrogen phosphate; the phosphorus supply material includes dipotassium hydrogen phosphate; and the magnesium supply material includes at least one of magnesium chloride and magnesium sulfate.
[0038] In some embodiments, the injection solvent can be specifically selected from water for injection.
[0039] Furthermore, the ingredients of the nutrient injection solution include, by mass fraction: calcium 0.8% to 3.5% (e.g., 1%, 1.2%, 1.5%, 1.8%, 2%, 2.2%, 2.5%, 2.8%, 3%, 3.2% or 3.4%), potassium 0.6% to 3.4% (e.g., 1%, 1.5%, 2%, 2.5%, 3% or 3.2%), phosphorus 0.1% to 1.5% (e.g., 0.2%, 0.3%, 0.5%, 0.8%, 1%, 1.2%, 1.3% or 1.4%), magnesium 0.05% to 1.0% (e.g., 0.08 %, 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6% or 0.8%), glucose 5%-30% (e.g., 5%, 10%, 15%, 18%, 20%, 22%, 25% or 28%), metal ion complexing agent 0.05%-1.0% (e.g., 0.05%, 0.1%, 0.3%, 0.5%, 0.8% or 1%) and activated carbon 0.02%-1.5% (e.g., 0.05%, 0.1%, 0.3%, 0.5%, 0.8%, 1%, 1.2% or 1.4%), and the rest is injection solvent.
[0040] Furthermore, the ingredients of the nutrient injection solution include, by mass fraction: calcium 1% to 3% (e.g., 1.2%, 1.5%, 1.8%, 2%, 2.2%, 2.5% or 2.8%), potassium 0.8% to 2.4% (e.g., 1%, 1.2%, 1.5%, 1.8%, 2% or 2.2%), phosphorus 0.25% to 1.0% (e.g., 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8% or 0.9%), magnesium 0.1% to 0.8% (e.g., 0.2%, 0.3% , 0.4%, 0.5%, 0.6% or 0.7%), glucose 5%-30% (e.g., 5%, 10%, 15%, 18%, 20%, 22%, 25% or 28%), metal ion complexing agent 0.05%-1.0% (e.g., 0.05%, 0.1%, 0.3%, 0.5%, 0.8% or 1%) and activated carbon 0.02%-1.5% (e.g., 0.05%, 0.1%, 0.3%, 0.5%, 0.8%, 1%, 1.2% or 1.4%), and the rest is injection solvent.
[0041] In the present invention, the activated carbon in the nutrient injection is designed for the nutrient injection for injection, and is used to remove impurities, decolorize and sterilize the nutrient injection. When the nutrient injection for injection is used to supplement nutrition for mammals, the activated carbon is filtered out during the injection process and will not enter the body of the mammal.
[0042] In some embodiments, the ingredients of the nutritional injection solution further include, by mass fraction: 0.5% to 5.0% (eg, 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4% or 4.5%) of vitamins.
[0043] In the present invention, the mass fraction of vitamins in the nutrient injection is controlled to be 0.5% to 5.0%, which is used to supplement the vitamins required by the mammalian mother after childbirth, and the phenomenon of over-supplementation will not occur. Generally, after childbirth, mammals lose their own energy and nutrients such as vitamins and amino acids on the one hand, and on the other hand, part of the energy of the mother and nutrients such as vitamins and amino acids form colostrum, which leads to the lack of nutrients in the mother itself.
[0044] Furthermore, the vitamins include at least one of B vitamins and vitamin C.
[0045] Furthermore, B vitamins generally include: vitamin B1, vitamin B2, vitamin B3 (niacin), vitamin B5 (pantothenic acid), vitamin B6, vitamin B9 (folic acid), vitamin B12 (cobalamin), etc.
[0046] In some embodiments, the ingredients of the nutrient injection solution further include, by mass fraction: 2.0% to 5.0% (eg, 2.2%, 2.5%, 2.8%, 3%, 3.2%, 3.5%, 4% or 4.5%) of amino acids.
[0047] In the present invention, the mass fraction of amino acids in the nutrient injection is controlled to be 2.0% to 5.0%, so as to supplement the amino acids required by mammals after delivery, and the phenomenon of over-supplementation will not occur.
[0048] Furthermore, the amino acid includes at least one of glutamic acid, lysine and arginine.
[0049] In the present invention, the nutrient injection can simultaneously supplement multiple elements such as calcium, phosphorus, magnesium, potassium, sugar and / or vitamins and / or amino acids, etc., and can effectively supplement the nutrient elements and energy of mammals after childbirth, and avoid diseases caused by the lack of nutrient elements and energy in mammals after childbirth. At the same time, the injection is in the form of an injection, which does not rely on the digestion and absorption capacity of the mammal itself, can achieve a good nutritional supplement effect, and the administration takes effect quickly, and generally 500 ml is sufficient.
[0050] like Figure 1 As shown, based on a general inventive concept, some embodiments of the present application further provide a method for preparing a nutrient injection solution for mammals, wherein the nutrient injection solution is the nutrient injection solution provided above; the preparation method comprises:
[0051] S1. Obtaining an injection solvent;
[0052] Specifically, in this embodiment, the injection solvent is water for injection.
[0053] S2. The calcium, potassium, phosphorus and magnesium supply materials are mixed with part of the injection solvent, and then glucose and a metal ion complexing agent are added, and the pH value is adjusted to acidic to obtain a mixed solution;
[0054] In some embodiments, step S2 further comprises: mixing the supply materials of calcium, potassium, phosphorus and magnesium with a portion of the injection solvent, then adding at least one of vitamins and amino acids, and adjusting the pH value to acidic to obtain a mixed solution.
[0055] Alternatively, in some embodiments, at least one of a vitamin and an amino acid is added to the injection solvent of the feed material mixed with calcium, potassium, phosphorus, and magnesium before the pH is adjusted.
[0056] In some embodiments, in step S2, the supply materials of calcium, potassium, phosphorus and magnesium are mixed with part of the injection solvent, and then at least one of vitamins and amino acids is added, and then glucose and a metal ion chelating agent are added, and the pH value is adjusted to acidic to obtain a mixed solution.
[0057] In some embodiments, the pH value of the nutrient injection solution is 3.0-6.5 (eg, 3.5, 4.0, 4.5, 5.0, 5.5 or 6.0).
[0058] Specifically, in some embodiments, about 60% of the preparation volume of water for injection is first added to the preparation tank, and then the calcium element carrier is added to the preparation tank; then the potassium element supply material, the phosphorus element supply material and the magnesium element supply material are added, and then at least one of vitamins and amino acids is added, and finally glucose and a metal ion chelating agent are added, and the pH value is adjusted to 3.0-6.5 to obtain a mixed solution.
[0059] In the present invention, by controlling the pH value range of the mixed solution, the stability of glucose in the nutrient injection solution is improved, thereby facilitating the provision of energy for postpartum mammalian mothers.
[0060] In some embodiments, the pH is adjusted to acidic using an inorganic acid or an organic acid.
[0061] In some embodiments, the inorganic acid comprises at least one of hydrochloric acid and boric acid, and the organic acid comprises lactic acid.
[0062] S3. The remaining injection solvent and the mixed solution are mixed to obtain a semi-finished product;
[0063] Specifically, in some embodiments, water for injection is added to the mixed solution to a full amount to obtain a semi-finished product.
[0064] S4. Mix the semi-finished product and activated carbon, and then filter to obtain an injection solution.
[0065] Specifically, in this embodiment, after the semi-finished product has passed the inspection, activated carbon is added and stirred for 5 minutes. After standing for 10 minutes, it is filtered (first through a 0.45 micron filter element, then through a 0.22 micron filter element), and then filled. After sterilization, light inspection, and packaging, the nutrient injection solution is obtained. After passing the full inspection, it is put into storage.
[0066] In some embodiments, the filtration includes primary filtration and secondary filtration, the diameter of the filter hole of the filter element of the primary filtration is 0.4-0.5 microns, and the diameter of the filter hole of the filter element of the secondary filtration is 0.2-0.3 microns. The method is used to prepare the above-mentioned nutrient injection solution, and the specific content of the nutrient injection solution can refer to the above-mentioned embodiment. Since the method adopts part or all of the technical solutions of the above-mentioned embodiment, it at least has all the beneficial effects brought by the technical solutions of the above-mentioned embodiment, which will not be repeated here.
[0067] In the present invention, the activated carbon is used for removing impurities, decolorizing and sterilizing in the production process of injection solution.
[0068] The present application will be further described below in conjunction with specific embodiments. It should be understood that these embodiments are intended only to illustrate the present application and are not intended to limit the scope of the present application. The experimental methods for which specific conditions are not specified in the following examples are usually measured according to national standards. If there is no corresponding national standard, then the conditions recommended by the manufacturer are followed.
[0069] Example 1
[0070] A nutrient injection for mammals, comprising, by mass fraction, 1% calcium, 0.8% potassium, 0.25% phosphorus, 0.1% magnesium, 0.5% vitamins, 2.0% amino acids, 5% glucose, 0.05% metal ion complexing agent, 0.02% activated carbon (for injection), and the rest being injection solvent.
[0071] Wherein, calcium supply materials include calcium chloride, calcium gluconate and calcium lactate;
[0072] The potassium supply material includes potassium chloride and dipotassium hydrogen phosphate;
[0073] The phosphorus supply material includes dipotassium hydrogen phosphate;
[0074] The magnesium supply material includes magnesium chloride;
[0075] Vitamins include B vitamins and vitamin C;
[0076] Amino acids include glutamate, lysine and arginine.
[0077] Example 2
[0078] A nutrient injection for mammals, comprising, by mass fraction, 1.5% calcium, 1.2% potassium, 0.4% phosphorus, 0.2% magnesium, 1% vitamins, 25% glucose, 0.2% metal ion complexing agent, 0.5% activated carbon (for injection), and the rest being injection solvent.
[0079] Wherein, calcium supply materials include calcium chloride, calcium gluconate and calcium lactate;
[0080] The potassium supply material includes potassium chloride and dipotassium hydrogen phosphate;
[0081] The phosphorus supply material includes dipotassium hydrogen phosphate;
[0082] The magnesium supply material includes magnesium sulfate;
[0083] Vitamins include B vitamins and vitamin C.
[0084] Example 3
[0085] A nutrient injection for mammals, comprising, by mass fraction, 2% calcium, 1.6% potassium, 0.6% phosphorus, 0.4% magnesium, 3.5% amino acids, 12.5% glucose, 0.5% metal ion complexing agent, 0.75% activated carbon (for injection), and the rest being injection solvent.
[0086] Wherein, calcium supply materials include calcium chloride, calcium gluconate and calcium lactate;
[0087] The potassium supply material includes potassium chloride and dipotassium hydrogen phosphate;
[0088] The phosphorus supply material includes dipotassium hydrogen phosphate;
[0089] The magnesium supply material includes magnesium chloride;
[0090] Amino acids include glutamate, lysine and arginine.
[0091] Example 4
[0092] A nutrient injection for mammals, comprising, by mass fraction, 3% calcium, 2.4% potassium, 1.0% phosphorus, 0.8% magnesium, 5.0% vitamins, 5.0% amino acids, 20% glucose, 1.0% metal ion complexing agent, 1.5% activated carbon (for injection), and the rest being injection solvent.
[0093] Wherein, calcium supply materials include calcium chloride, calcium gluconate and calcium lactate;
[0094] The potassium supply material includes potassium chloride and dipotassium hydrogen phosphate;
[0095] The phosphorus supply material includes dipotassium hydrogen phosphate;
[0096] The magnesium supply material includes magnesium chloride;
[0097] Vitamins include B vitamins and vitamin C;
[0098] Amino acids include glutamate, lysine and arginine.
[0099] Example 5
[0100] A nutrient injection for mammals, comprising, by mass fraction, 2% calcium, 1.5% potassium, 0.5% phosphorus, 0.3% magnesium, 30% glucose, 0.8% metal ion complexing agent, 1% activated carbon (for injection), and the rest being injection solvent.
[0101] Wherein, calcium supply materials include calcium chloride, calcium gluconate and calcium lactate;
[0102] The potassium supply material includes potassium chloride;
[0103] The phosphorus supply material includes dipotassium hydrogen phosphate;
[0104] The magnesium supply material includes magnesium chloride.
[0105] Comparative Example 1
[0106] A nutrient injection for mammals, comprising, by mass fraction, 2% calcium, 15% glucose, 0.5% metal ion complexing agent, 1% activated carbon (for injection), and the rest being injection solvent.
[0107] Among them, calcium supply materials include calcium gluconate and calcium lactate.
[0108] Comparative Example 2
[0109] A nutrient injection for mammals, comprising, by mass fraction, 3% calcium, 25% glucose, 0.5% metal ion complexing agent, 1% activated carbon (for injection), and the rest being injection solvent.
[0110] Among them, the calcium supply material includes calcium gluconate.
[0111] The stability test was carried out on the nutritional injection products for mammals provided in Examples 1-5 and Comparative Examples 1-2. The test process included storing them under high temperature (50°C), light (4500±500lx) and freezing (refrigerator freezer) conditions for a certain period of time (3 months, 6 months, 9 months, 12 months and 18 months), and observing their conditions.
[0112] It should be noted that, since the stability test results of the nutrient injection for mammals in Examples 1-3 are similar, only the results of Example 3 are specifically described below, and the results are shown in Table 1 below.
[0113] Table 1 Stability test results of the nutrient injection for mammals in Example 3
[0114]
[0115] It can be seen from Table 1 that the nutritional injection provided by the present application appears as a colorless clear liquid within 3 to 12 months of observation, which indicates that the nutritional injection product obtained according to the technical solution of the present application has good stability, and can maintain stability for 12 months under high temperature or light, and can maintain stability for 18 months under freezing conditions.
[0116] Since the stability test results of the nutrient injection for mammals in Comparative Example 1 and Comparative Example 2 are similar, only the results of Comparative Example 2 are specifically described below, and the results are shown in Table 2.
[0117] Table 2 Stability test results of the nutrient injection for mammals in Comparative Example 2
[0118]
[0119] It can be seen from Table 2 that under high temperature, light and freezing conditions, the nutrient injection solution for mammals in Comparative Example 2 is a colorless clear liquid at 3 to 9 months; at 12 months, the color turns light yellow under high temperature and light, and freezes into a white solid under freezing conditions.
[0120] Comparing the results of Table 1 and Table 2, it can be seen that the stability of the nutritional injection products for mammals in Examples 1-5 prepared according to the present invention is better than that in Comparative Examples 1-2.
[0121] The therapeutic effect test was conducted on the nutrient injection products for mammals provided in Examples 1-5 and Comparative Examples 1-2. The test process included nutritional supplementation for postpartum mammals. The specific method was as follows:
[0122] After giving birth, mammalian female animals sometimes have symptoms of lying on the ground due to physical exhaustion, loss of body fluids and energy; the nutrient injection solution is intravenously injected into the mammalian female animals after giving birth, and the timer starts after the injection is completed, and the time when the female animals slowly stand up is recorded, which is used as the time when the nutrient injection solution takes effect. Table 2 shows the therapeutic effects of the nutrient injection solutions provided by Examples 1-5 and Comparative Examples 1-2.
[0123] Table 2 The therapeutic effects of the nutrient injection provided by Examples 1-5 and Comparative Examples 1-2
[0124] Onset time Effective dosage Example 1 30min 500ml Example 2 35min 500ml Example 3 35min 500ml Example 4 35min 500ml Example 5 30min 500ml Comparative Example 1 80min 1000ml Comparative Example 2 100min 1000ml
[0125] It can be seen from Table 2 that the nutrient injection provided in the embodiments of the present application can provide nutritional supplements to lactating mammals after delivery in a shorter time and at a lower dosage.
[0126] Compared with Comparative Examples 1 and 2, the nutritional injection according to the present invention, due to the presence of potassium, magnesium and phosphorus, is conducive to accelerating the absorption of nutrients by mammals, thereby achieving the effect of supplementing nutrition in a shorter time and with a lower injection dosage.
[0127] Various embodiments of the present application may be presented in the form of a range; it should be understood that the description in the form of a range is only for convenience and brevity, and should not be understood as a rigid limitation on the scope of the present application; therefore, the range description should be considered to have specifically disclosed all possible sub-ranges and single numerical values within the range. For example, the range description from 1 to 6 should be considered to have specifically disclosed sub-ranges, such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6, etc., as well as single numbers within the range, such as 1, 2, 3, 4, 5 and 6, which apply regardless of the range. In addition, whenever a numerical range is indicated herein, it is meant to include any cited number (fractional or integer) within the indicated range.
[0128] In the present application, in the absence of any contrary description, the directional words used, such as "upper" and "lower", are specifically the directions of the drawings in the accompanying drawings. In addition, in the description of the present specification, the terms "including", "comprising", etc. refer to "including but not limited to". In this article, relational terms such as "first" and "second" are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply that there is any such actual relationship or order between these entities or operations. In this article, "and / or" describes the association relationship of the associated objects, indicating that there may be three relationships, for example, A and / or B, which can represent: A exists alone, A and B exist at the same time, and B exists alone. Wherein A, B can be singular or plural. In this article, "at least one" refers to one or more, and "plural" refers to two or more. "At least one", "at least one of the following" or similar expressions refer to any combination of these items, including any combination of singular or plural items. For example, "at least one of a, b, or c", or "at least one of a, b and c", can both mean: a, b, c, ab (i.e. a and b), ac, bc or abc, where a, b, c can be single or plural, respectively.
[0129] The above description is only a specific implementation of the present application, so that those skilled in the art can understand or implement the present application. Various modifications to these embodiments will be apparent to those skilled in the art, and the general principles defined herein can be implemented in other embodiments without departing from the spirit or scope of the present application. Therefore, the present application will not be limited to the embodiments shown herein, but will conform to the widest range consistent with the principles and novel features applied for herein.
Claims
1. A nutrient injection for mammals, characterized in that: The ingredients of the nutrient injection solution include, by mass fraction, 0.6% to 5% calcium, 0.5% to 3.8% potassium, 0.05% to 2.0% phosphorus, 0.02% to 1.5% magnesium, 5% to 30% glucose, 0.05% to 1.0% metal ion complexing agent, and 0.02% to 1.5% activated carbon, and the rest is injection solution solvent.
2. The nutrient injection solution for mammals according to claim 1, characterized in that: The ingredients of the nutrient injection solution include, by mass fraction, 0.8% to 3.5% calcium, 0.6% to 3.4% potassium, 0.1% to 1.5% phosphorus, 0.05% to 1.0% magnesium, 5% to 30% glucose, 0.05% to 1.0% metal ion complexing agent, and 0.02% to 1.5% activated carbon, with the remainder being injection solution solvent.
3. The nutrient injection solution for mammals according to claim 2, characterized in that: The ingredients of the nutrient injection solution include, by mass fraction, 1% to 3% calcium, 0.8% to 2.4% potassium, 0.25% to 1.0% phosphorus, 0.1% to 0.8% magnesium, 5% to 30% glucose, 0.05% to 1.0% metal ion complexing agent, and 0.02% to 1.5% activated carbon, with the remainder being injection solution solvent.
4. The nutrient injection solution for mammals according to any one of claims 1 to 3, characterized in that: The calcium supply material includes at least one of calcium chloride, calcium gluconate and calcium lactate; and / or The potassium supply material includes at least one of potassium chloride and dipotassium hydrogen phosphate; and / or The phosphorus supply material includes at least one of dipotassium hydrogen phosphate, potassium dihydrogen phosphate and disodium hydrogen phosphate; and / or The magnesium supply material includes at least one of magnesium chloride and magnesium sulfate; and / or The metal ion complexing agent includes at least one of EDTA disodium salt, citric acid and tartaric acid.
5. The nutrient injection solution for mammals according to any one of claims 1 to 3, characterized in that: The ingredients of the nutrient injection solution further include, by mass fraction: 0.5% to 5.0% of vitamins; and / or The vitamins include at least one of B vitamins and vitamin C.
6. The nutrient injection solution for mammals according to any one of claims 1 to 3, characterized in that: The ingredients of the nutrient injection solution further include, by mass fraction: 2.0% to 5.0% of amino acids; and / or The amino acid includes at least one of glutamic acid, lysine and arginine.
7. A method for preparing a nutrient injection solution for mammals, characterized in that: The nutrient injection solution is the nutrient injection solution according to any one of claims 1 to 6; the preparation method comprises the following steps: 1) obtaining an injection solvent; 2) mixing the supply materials of calcium, potassium, phosphorus and magnesium with part of the injection solvent, then adding glucose and a metal ion complexing agent, and adjusting the pH value to acidic to obtain a mixed solution; 3) mixing the remaining injection solvent with the mixed solution to obtain a semi-finished product; 4) Mixing the semi-finished product with activated carbon, and then filtering to obtain an injection solution.
8. The method for preparing a nutrient injection for mammals according to claim 7, characterized in that: The step 2) further comprises: mixing the supply materials of calcium, potassium, phosphorus and magnesium with part of the injection solvent, and then adding at least one of vitamins and amino acids; and / or The pH value of the mixed solution is 3.0-6.
5.
9. The method for preparing a nutrient injection solution for mammals according to claim 7 or 8, characterized in that: The pH value is adjusted to acidic using an inorganic acid or an organic acid; wherein, The inorganic acid comprises at least one of hydrochloric acid and boric acid; The organic acid includes lactic acid.
10. The method for preparing a nutrient injection solution for mammals according to claim 7 or 8, characterized in that: The filtration includes primary filtration and secondary filtration. The diameter of the filter hole of the filter element of the primary filtration is 0.4-0.5 microns, and the diameter of the filter hole of the filter element of the secondary filtration is 0.2-0.3 microns.
